Search Results 1091-1100 of 18141 for monoclonal antibody

1. Coronavirus Disease 2019 (Covid 19 Clinical Trials - Mayo Clinic Research

   ... antibody detectable targets on cancer cells (cancer vaccines or antibody ... Monoclonal Antibodies To Treat Hospitalized Patients With COVID-19 Rochester, MN.

2. A Study To Evaluate Safety, PK, PD And Efficacy Of AZD5492, A T Cell-engaging Antibody Targeting CD20 In Subjects With R/R B-Cell Malignancies. - Mayo Clinic

   A Study To Evaluate Safety, PK, PD And Efficacy Of AZD5492, A T Cell-engaging Antibody Targeting CD20 In Subjects With R/R B-Cell Malignancies. Print ...

3. Coronavirus Disease 2019 Clinical Trials - Mayo Clinic Research

   ... antibody detectable targets on cancer cells (cancer vaccines or antibody ... Monoclonal Antibodies To Treat Hospitalized Patients With COVID-19 Rochester, MN.

4. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

   ... monoclonal antibodies): 2 weeks; Immune-checkpoint inhibitors (i.e., anti-PD-1, anti-PD-L1, or anti-CTLA-4): 4 weeks; Other monoclonal antibodies, antibody ...

5. An Investigational Immuno-therapy Study Of Nivolumab, Compared To Placebo, In Patients With Bladder Or Upper Urinary Tract Cancer, Following Surgery To Remove The Cancer - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Sex and Reproductive Status. WOCBP who are pregnant or breastfeeding. Women with a ...

6. Study Of Ociperlimab In Combination With Tislelizumab In Advanced Solid Tumors - Mayo Clinic

   ... antibody test and negative HCV ribonucleic acid test) may be enrolled. ... History of severe hypersensitivity reactions to other monoclonal antibodies.

7. Anti-Bullous Pemphigoid Antibodies in Patients with Neurological Disease - Mayo Clinic

   The purpose of this study is to learn more about Lewy Body disease and a skin condition called Bullous Pemphigoid. Participation eligibility. Participant ...

8. Throat Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells. Efficacy of Electrical Stimulation for ...

9. Phase II Single-arm Study of Tepotinib Combined with Cetuximab - Mayo Clinic

   ... antibody targeted therapy due to mesenchymal epithelial transition factor (MET) amplification. ... monoclonal antibody therapy (panitumumab or cetuximab) ...

10. A Study Of Long-acting Antibodies Alone And In Combinations For Moderate To Severe Ulcerative Colitis - Mayo Clinic

    This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary ...